CAPAZ-2D: Continuous Glucose Monitoring to Augment and Personalize Self-Management of Type 2 Diabetes in Hispanic/Latinx Young Adults

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Type 2 diabetes in increasing common in young adults. Utilizing a mixed-methods, community-based approach, this study offers continuous glucose monitors (CGMs) to young adults with type 2 diabetes for 30 days, and collects both quantitative and qualitative data to understand barriers and facilitators of CGM use, participants' changes in awareness of glucose patterns while using the CGM, and preferences for a CGM-based self-management intervention.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 45
Healthy Volunteers: f
View:

• adult 18-45 years of age

• diagnosis of type 2 diabetes in the last 5 years, as evidenced in the electronic medical record

• no prior use or experience with wearable CGMs

• possession of a smart phone that is compatible with Dexcom CGM sensors (nearly all smartphones are compatible) and willing to download and utilize the Dexcom CGM app

• fluency in English or Spanish

Locations
United States
California
Scripps Health
RECRUITING
San Diego
Contact Information
Primary
Jessica L McCurley, PhD, MPH
jlmccurley@sdsu.edu
619-594-2132
Time Frame
Start Date: 2025-10-02
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 40
Treatments
Experimental: CGM Wear
Participants will wear a continuous glucose monitor for 30 days. They will also wear a FitBit activity tracker watch and complete weekly surveys to report diabetes self-management behaviors.
Related Therapeutic Areas
Sponsors
Collaborators: Scripps Health
Leads: San Diego State University

This content was sourced from clinicaltrials.gov

Similar Clinical Trials